Cargando…

S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors

The calcium-binding protein S100P is expressed in a variety of human cancer cells and is important in cancer cell growth and invasion. Using differential display, we found S100P is overexpressed in human hepatocellular carcinoma (HCC). We examined the expression of 305 unifocal, primary HCC tumors u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Ray-Hwang, Chang, Ko-Tung, Chen, Yu-Ling, Hsu, Hey-Chi, Lee, Po-Huang, Lai, Po-Lin, Jeng, Yung-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681902/ https://www.ncbi.nlm.nih.gov/pubmed/23785431 http://dx.doi.org/10.1371/journal.pone.0065501

Ejemplares similares

Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor Prognosis
por: Chen, Yu-Ling, et al.
Publicado: (2013)

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
por: Lin, Zhong-Zhe, et al.
Publicado: (2010)

Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study
por: Hsu, Chia-Yang, et al.
Publicado: (2017)

Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2021)

Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion
por: Lee, Yu-Hsin, et al.
Publicado: (2016)

Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma
por: Bang, Heejin, et al.
Publicado: (2015)

Association of Tumor Hydroxyindole O-Methyltransferase and Serum 5-Methoxytryptophan with Long-Term Survival of Hepatocellular Carcinoma
por: Ko, Bor-Sheng, et al.
Publicado: (2021)

Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma
por: Huang, Wei-Ju, et al.
Publicado: (2015)

Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma
por: Park, Yong Keun, et al.
Publicado: (2017)

Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade
por: Ho, Shu-Yein, et al.
Publicado: (2020)

Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients
por: Rosenbaum, Brooke E., et al.
Publicado: (2017)

A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma
por: Ho, Shu-Yein, et al.
Publicado: (2022)

Prognostic Factors for Pulmonary Metastasectomy in Hepatocellular Carcinoma
por: Kuo, Shuenn-Wen, et al.
Publicado: (2006)

Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
por: Han, Kyung Hee, et al.
Publicado: (2017)

Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score
por: Ho, Shu-Yein, et al.
Publicado: (2022)

Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer
por: Wang, Dong, et al.
Publicado: (2019)

Outcomes of patients with different lepidic percentage and tumor size of stage I lung adenocarcinoma
por: Liu, Chia, et al.
Publicado: (2022)

Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy
por: Shen, Ying-Chun, et al.
Publicado: (2021)

Risk Group Stratification for Recurrence-Free Survival and Early Tumor Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Cha, Dong Ik, et al.
Publicado: (2023)

SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2020)

Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Xiang, Shixin, et al.
Publicado: (2021)

Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
por: Tsai, Ping-Chung, et al.
Publicado: (2022)

The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients
por: Liang, Yuxin, et al.
Publicado: (2022)

Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Decreased Expression of PTPN12 Correlates with Tumor Recurrence and Poor Survival of Patients with Hepatocellular Carcinoma
por: Luo, Rong-Zhen, et al.
Publicado: (2014)

The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular Carcinoma
por: Hsiao, Yung-Fang, et al.
Publicado: (2021)

Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022)

Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
por: Lin, Zhong-Zhe, et al.
Publicado: (2013)

Imaging prognostication and tumor biology in hepatocellular carcinoma
por: Kadi, Diana, et al.
Publicado: (2023)

IDO and intra‐tumoral neutrophils were independent prognostic factors for overall survival for hepatocellular carcinoma
por: Wang, Yan, et al.
Publicado: (2019)

Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer
por: Mony, Jyothi Thyagabhavan, et al.
Publicado: (2018)

Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma
por: Chen, Yunyang, et al.
Publicado: (2019)

The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early‐stage hepatocellular carcinoma
por: Chen, Zhi‐Yuan, et al.
Publicado: (2021)

Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number
por: Hu, Xin-Sheng, et al.
Publicado: (2022)

Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10
por: Cheng, Wei, et al.
Publicado: (2017)

Clinical Course and Predictors of Subsequent Recurrence and Survival of Patients With Ipsilateral Breast Tumor Recurrence
por: Baek, Soo Yeon, et al.
Publicado: (2022)

Fusobacterium Nucleatum-Induced Tumor Mutation Burden Predicts Poor Survival of Gastric Cancer Patients
por: Hsieh, Yung-Yu, et al.
Publicado: (2022)

Long-Term Survival in Patients With T2 Hepatocellular Carcinoma After Primary Curative Resection Can Be Further Stratified by Tumor Size
por: Ho, Cheng-Maw, et al.
Publicado: (2014)

S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma
por: Maletzki, Claudia, et al.
Publicado: (2012)

Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis
por: Wang, Jiangfeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pea3s7bqjg71lcujdd70jh9cep